Fredun Pharmaceuticals Ltd. logo

Fredun Pharmaceuticals Ltd. (FREDUN)

Market Closed
11 Aug, 22:00
MSE MSE
1,258. 00
+35
+2.8618%
2.68B Market Cap
- P/E Ratio
2.8% Div Yield
2,975 Volume
- Eps
1,223
Previous Close
Add Transaction
Day Range
1,230.15 1,258
Year Range
338.73 1,331.7
Want to track FREDUN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Fredun Pharmaceuticals Ltd. (FREDUN) Statistics

Valuation metrics

Market Cap 2.68B
Enterprise value 22.15B
Trailing P/E (ttm) 48.98
Forward P/E -
PEG ratio 0.6
Price/Sales (ttm) 3.22
Price/Book (mrq) 7.34
Enterprise Value/Revenue 3.47
Enterprise Value/EBITDA 23.43

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 73.96K
Average volume (90 days) 23.26K

Price summary

52-Week low 338.73
52-Week high 1,331.7
Beta -
50-Day moving average 1,829.78
200-Day moving average 1,918.73

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.23
Trailing annual dividend yield 0.0002%
5-Year annual dividend yield -
Payout ratio -
Dividend Date 23 Jun 2026
Ex-Dividend Date 23 Jun 2026
Last split factor 3:1
Last split Date 16 Jul 2026

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin 0.06%
Operating margin 0.14%

Operational effectiveness

Return on assets 0.06%
Return on equity 0.2%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 389.06
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 22.82
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 39.58
Total debt (mrq) -
Total Debt/Equity (mrq) 0.8
Current ratio (mrq) 1.68%
Book value per share (mrq) 169.41

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -